Navigation Links
ExonHit Builds A New Organisation
Date:1/16/2008

PARIS, January 16 /PRNewswire-FirstCall/ -- ExonHit Therapeutics, a drug and diagnostic discovery company, today announced that it has created two commercial business units: the Molecular Diagnostics and Genomic Services Unit and the Therapeutics Unit.

The accomplishments of the last years and recent progress in core programs have laid the foundation to implement a new structure more targeted to the market. John Jaskowiak has been appointed as Head of the Molecular Diagnostics and Genomic Services Unit and Matt Pando has been appointed as Head of the Therapeutics Unit. In addition, the company has recruited two new collaborators: Anders Ingvarsson as Vice-President of Marketing of Molecular Diagnostics and James Douglas as Vice-President of Corporate Strategy and Projects. This organization will receive support from the Financial Department headed by Philippe Rousseau and the Legal Department headed by Frederique Schlumberger.

Anders Ingvarsson is Swedish and has a dual academic background in Chemical Engineering and Marketing. He has been instrumental in launching start-up companies and developing diagnostics distribution channels in Europe. He worked from 2001 to 2007 for Sangtec Molecular Diagnostics as Executive Vice President, achieving key collaborations and partnerships with major diagnostics companies, before creating his own consulting firm in Stockholm in 2007. He will be responsible for the design and implementation of marketing plans for ExonHit Therapeutics diagnostic products.

James Douglas was previously Senior Vice President, Sales and Marketing of the German diagnostic company, Epigenomics. Previous to Epigenomics, Mr. Douglas was Vice President, Sales and Marketing for Biosite where he was responsible for the launch of the cardiovascular diagnostic, BNP. He also served as Vice President, Marketing for Gen-Probe, was Director of Marketing at Centocor and held sales and marketing positions with Sanofi Diagnostics Pasteur a
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ExonHit and bioMerieux Amend Their Strategic Partnership
2. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
3. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
4. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Massachusetts e SHENZHEN , ... Co., LTD, (BGI Tech), una filiale di BGI, la ... lancio mondiale di un nuovo servizio di sequenziamento dell,intero ... di Complete Genomics. Complete Genomics, molto ... tecnologie di sequenziamento proprietarie con il 99.999% di precisione ...
(Date:7/22/2014)... SHENZHEN, China , July 22, ... (BGI Tech), a subsidiary of BGI, the world,s ... of a new human whole exome sequencing service ... offered service includes in-depth bioinformatics analysis and SNP ... December 31, 2014. Complete Genomics, ...
(Date:7/22/2014)... 2014 In chemical and petrochemical ... common sight. The rapid rise of TDL analyzers ... established as a core gas measurement technology, and ... them the gas analyzer technology of choice for ... in some processes have limited their application range. ...
(Date:7/22/2014)... 22, 2014  The Broad Institute today announced ... Ted Stanley aimed at galvanizing scientific ... based on molecular understanding to hundreds of millions ... The Stanley commitment – the largest ever in ... research in general – will support research by ...
Breaking Biology Technology:BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3METTLER TOLEDO Shows How Tunable Diode Lasers (TDLs) Can Be Installed Where No TDLs Have Gone Before 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 3$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 4$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 5$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 6$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 7$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 8$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 9$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 10
... in Second of Two Phase 3 Trials ... - Trial Design Was Reviewed Under Special Protocol Assessment Procedure ... ... SPPI ) today announced today that it has,begun enrolling patients in its second ...
... Prize winner Richard Feynman presented a talk entitled There,s Plenty ... was no physical reason why humans couldn,t manipulate atoms. ... the new atom positions remains. How do you know ... 7, 2007 issue of Science, IBM and Imago have taken ...
... September 11, 2007 - 11:00 a.m. ET; 8:00 a.m. ... /PRNewswire-FirstCall/ - MIGENIX,Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage ... call and webcast on Tuesday,September 11, 2007 at 11:00 ... the first fiscal quarter ended July 31, 2007. An ...
Cached Biology Technology:Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer 2Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer 3Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer 4IBM and Imago find a crucial difficulty in semiconductor device scaling 2MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification 2
(Date:7/22/2014)... that mutations in prickle genes cause epilepsy, which ... repeated seizures over time. However, the mechanism responsible ... new University of Iowa study, published online July ... Academy of Sciences , reveals a novel pathway ... identified the basic cellular mechanism that goes awry ...
(Date:7/22/2014)... The Carlton Complex fires started on July 14, 2014, by ... Valley. The Carlton Complex consists of four fires: Stokes Fire, ... The Stokes and Gold Hikes fires are now one larger ... the area burning is currently over 243,000 acres in size. ... to the high fire danger. Public and firefighter safety is ...
(Date:7/22/2014)... as the ,1000 Bull Genomes Project, aims to accelerate ... while also improving animal health and welfare. Results of ... whole genomes of 234 individual bulls whose direct descendants ... in the journal Nature Genetics . , According ... to reduce or eliminate hereditary diseases and to improve ...
Breaking Biology News(10 mins):UI study finds potential genetic link between epilepsy and neurodegenerative disorders 2Whole-genome sequencing of bulls in key beef and dairy breeds 2
... loss of limb control in individuals with spinal cord ... the neural pathways between brain and spinal cord, although ... remain functional. An artificial neural connection that bridges the ... potential to ameliorate the functional loss. Yukio Nishimura, ...
... facing unprecedented threat from climate change, overfishing, pollution, ... Florida researcher is helping coordinate national efforts to ... ocean for food, medicine, transportation and recreation, yet ... spanning 70 percent of the Earth,s surface are ...
... 10, 2013) The ongoing dance between a ... evolves. While human adenoviruses typically cause mild infections, recent ... severe, sometime fatal, human infections. Researchers from ... Provincial Laboratory for Public Health, School of Systems Biology, ...
Cached Biology News:Scientists stress need for national marine biodiversity observation network 2Scientists stress need for national marine biodiversity observation network 3
... Filter Plates are offered in several versions. ... depth filter plates are ideal to prepare ... is simple, versatile, and necessary to prevent ... 10 um glass fiber and 20 um ...
... First-Strand cDNA Labeling Kit with CyScribe ... the generation and purification of Cy3- ... together for complete cDNA labeling and ... used for performing labeling reactions with ...
... CyScribe First-Strand cDNA Labeling System - ... 50 reactions. For the generation and ... reagents are packaged together for complete ... protocols can be used for performing ...
Canine Serum...
Biology Products: